Dr. Olorunseun Ogunwobi obtained a medical degree from the University of Ibadan, Nigeria, a master's degree in biomedicine from the University of Hull, United Kingdom, a master's degree in clinical and translational science from the University of Florida, Gainesville, USA, and a PhD in molecular medicine from the University of East Anglia, Norwich, United Kingdom. He is the founding Director of the Hunter College Center for Cancer Health Disparities Research, a tenured Associate Professor of Biological Sciences at Hunter College of The City University of New York, and a member of faculty in the Biology and Biochemistry PhD programs at The Graduate Center of The City University of New York. Dr. Ogunwobi is a Contact Principal Investigator of the Synergistic Partnership for Enhancing Equity in Cancer Health (SPEECH) funded by U54 grants from the National Cancer Institute. He is using our orthotopic syngeneic mouse models of metastatic hepatocellular carcinoma and colon cancer to understand the mechanisms of metastasis with particular interest in the role of circulating tumor cell biology.
Research Keywords & Expertise
Cancer
Prostate Cancer
circulating tumor cell...
PVT1
Cancer health disparit...
Fingerprints
83%
Cancer
27%
Prostate Cancer
23%
PVT1
10%
circulating tumor cells
5%
Cancer health disparities
Short Biography
Dr. Olorunseun Ogunwobi obtained a medical degree from the University of Ibadan, Nigeria, a master's degree in biomedicine from the University of Hull, United Kingdom, a master's degree in clinical and translational science from the University of Florida, Gainesville, USA, and a PhD in molecular medicine from the University of East Anglia, Norwich, United Kingdom. He is the founding Director of the Hunter College Center for Cancer Health Disparities Research, a tenured Associate Professor of Biological Sciences at Hunter College of The City University of New York, and a member of faculty in the Biology and Biochemistry PhD programs at The Graduate Center of The City University of New York. Dr. Ogunwobi is a Contact Principal Investigator of the Synergistic Partnership for Enhancing Equity in Cancer Health (SPEECH) funded by U54 grants from the National Cancer Institute. He is using our orthotopic syngeneic mouse models of metastatic hepatocellular carcinoma and colon cancer to understand the mechanisms of metastasis with particular interest in the role of circulating tumor cell biology.